Show simple item record

dc.contributor.authorGil Mira, María del Mar 
dc.contributor.authorRodríguez Fernández, Miguel
dc.contributor.authorElger, Tania
dc.contributor.authorAkolekar, R.
dc.contributor.authorSyngelaki, A.
dc.contributor.authorDe Paco Matallana, C.
dc.contributor.authorMolina, ,F. S.
dc.contributor.authorGallardo Arocena, M.
dc.contributor.authorChaveeva, P.
dc.contributor.authorPersico, N.
dc.contributor.authorAccurti, V.
dc.contributor.authorKagan, K. O.
dc.contributor.authorProdan, N.
dc.contributor.authorCruz, J.
dc.contributor.authorNicolaides, K. H.
dc.description.abstractObjective To estimate the risk of fetal loss associated with chorionic villus sampling (CVS) in twin pregnancy, using propensity score analysis. Methods This was a multicenter cohort study of women with twin pregnancy undergoing ultrasound examination at 11–13 weeks' gestation, performed in eight fetal medicine units in which the leadership were trained at the Harris Birthright Research Centre for Fetal Medicine in London, UK, and in which the protocols for screening, invasive testing and pregnancy management are similar. The risk of death of at least one fetus was compared between pregnancies that had and those that did not have CVS, after propensity score matching (1:1 ratio). This procedure created two comparable groups by balancing the maternal and pregnancy characteristics that lead to CVS being performed, similar to how randomization operates in a randomized clinical trial. Results The study population of 8581 twin pregnancies included 445 that had CVS. Death of one or two fetuses at any stage during pregnancy occurred in 11.5% (51/445) of pregnancies in the CVS group and in 6.3% (515/8136) in the non-CVS group (P < 0.001). The propensity score algorithm matched 258 cases that had CVS with 258 non-CVS cases; there was at least one fetal loss in 29 (11.2%) cases in the CVS group and in 35 (13.6%) cases in the matched non-CVS group (odds ratio (OR), 0.81; 95% CI, 0.48–1.35; P = 0.415). However, there was a significant interaction between the risk of fetal loss after CVS and the background risk of fetal loss; when the background risk was higher, the risk of fetal loss after CVS decreased (OR, 0.46; 95% CI, 0.23–0.90), while, in pregnancies with a lower background risk of fetal loss, the risk of fetal loss after CVS increased (OR, 2.45; 95% CI, 0.95–7.13). The effects were statistically significantly different (P-value of the interaction = 0.005). For a pregnancy in which the background risk of fetal loss was about 6% (the same as in our non-CVS population), there was no change in the risk of fetal loss after CVS, but, when the background risk was more than 6%, the posterior risk was paradoxically reduced, and when the background risk was less than 6%, the posterior risk increased exponentially; for example, if the background risk of fetal loss was 2.0%, the relative risk was 2.8 and the posterior risk was 5.6%. Conclusion In twin pregnancy, after accounting for the risk factors that lead to both CVS and spontaneous fetal loss and confining the analysis to pregnancies at lower prior risk, CVS seems to increase the risk of fetal loss by about 3.5% above the patient's background risk. © 2021 International Society of Ultrasound in Obstetrics and
dc.publisherUltrasound in Obstetrics & gynecologyspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.subjectFirst-trimester screeningspa
dc.subjectChorionic villus samplingspa
dc.subjectPregnancy complicationsspa
dc.subjectAdverse pregnancy outcomespa
dc.subjectInvasive testingspa
dc.subjectInvasive proceduresspa
dc.subjectPrenatal diagnosisspa
dc.titleRisk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching
dc.description.extent226 KBspa

Files in this item

3.- Risk of fetal loss after ...225.5KbPDFView/Open

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España